Billion to One

Billion to One is a precision diagnostics company that quantifies biology to create powerful molecular diagnostics that are extremely accurate and accessible to all. Four Rivers led the $55M Series B financing in 2021, alongside Neotribe and Humminbird Ventures. Billion to One completed its initial public offering in November of 2025.

billiontoone.com/